Treatment of Relapsed/Refractory Multiple Myeloma with Thalidomide-based Regimens: Identification of Prognostic Factors
暂无分享,去创建一个
M. Dimopoulos | E. Kastritis | K. Zervas | D. Anagnostou | D. Gika | A. Anagnostopoulos | A. Tassidou | A. Pouli | N. Anagnostopoulos | A. Zomas | G. Hamilos | M. Zorzou